Excerpts

However, corrected post-hoc comparisons showed only a marginally significant difference between pet and WSC dogs (z = 2.55, p = 0.05; Table S12 Supplementary Material ).

We replicated also the strong influence of embryonic development, kidney transmembrane transporter activity, and kidney and urogenital system morphology in the genesis of CKD from our previous findings 7 : enrichment of all 148 previously identified gene sets was nominally significant (p-value < 0.05).

It can be seen from Table 4 that with the increase of age, the extrauterine measurement diameter showed an overall trend of increasing, but P < 0.05.

Regarding the ASI, subjects with the G/G genotype showed higher ASI levels than those with the T/T genotype with marginal significance (19.78 ± 11.90 vs. 15.48 ± 9.59, P = 0.05).

Seventy CpGs (in 41 genes) showed nominally significant associations ( P < 0.05) with AD-ND codependence in both AAs and EAs.

A post-hoc power analysis was conducted using G*Power 3.1 to estimate the observed power for between-group comparisons that were nominally significant (uncorrected p < 0.05) but did not survive the FDR correction.

In addition, the values determined in super-tasters at 2.5 s were higher than those of non-tasters ( P = 0.0012; Newman-Keuls test) and of medium taster, although at the limit of statistical significance ( P = 0.05; Newman-Keuls test), and those of PAV/PAV subjects were higher than those of AVI/AVI subjects, also in this case at the limit of significance ( P = 0.05; Newman-Keuls test).

greater resorption of the EMD was seen in the mock transfected group when compared to the miR-153 transfected group), the difference did not reach statistical significance ( P < 0.05).

A marginally significant main effect was obtained (F 4,80 = 2.48, p = 0.05).

If p < 0.05, there was significant difference; if p < 0.01, the difference was extremely significant; if p > 0.05, there was no significant difference.

23 , values are considered statistical robust when at least 50% of the climate models show a significant trend (p < 0.05) and at least 80% of those have the same trend sign.

10 nM dapagliflozin strongly reduced release-inhibition by 11 mM glucose to 29% of control (p = 0.016), and showed a trend towards an inhibitory effect on secretion at low glucose (51% of control, p = 0.050).

Six OTUs had an abundance of more than 2% of the total sequences, and four of these (OTU00026, OTU00034, OTU00037, and OTU00046, all classified as Ascomycota) showed a significant or marginally significant difference between the Early Stage and the Late Stage (p ≤ 0.05).

Final models were determined using backward elimination technique and terms dropped if they failed to reach statistical significance ( p = 0.05) and when possible, we also used AIC criterion for model fit to the data.

We found trends towards decreased NAA, GABA and glutamate at three months that was barely significant for glutamate (p < 0.05; F 3,36 = 3.1) and was protected by fingolimod.

2 E-G, the mRNA expression of Claudin-1 , Occludin , and ZO-1 in the colon of LOP group showed a decreasing trend compared with those in CK group ( p > 0.05). γ -PGAM treatment enhanced the expression of Claudin-1 , Occludin , and ZO-1 genes at the mRNA levels compared with the LOP group, albeit there was an upward trend observed in γ-PGAL and γ-PGAH groups( p < 0.05 or < 0.01).

7 ), and a highly significant positive correlation was observed between the degradation extent of n -hexadecane and the DHA activity (R = 0.587, p < 0.05, n = 16), even though part of the n -hexadecane was degraded by the electrokinetic treatment in Bio1-EK.

The adequacy of the models was assessed using an analysis of variance, which indicated that the regression models were highly significant ( P < 0.05).

In the Mendelian randomisation model adjusted for age, gender and principal components (PCs) (Model 3, Table 2 ), each 10 mm Hg increase in DBP and MAP was associated with a 4.5 μm decrease (P = 0.01) in CRAE, and the effect size of MAP on CRAE remained similar (β = −2.6 μm) and was marginally significant (P = 0.05).

Importantly, excluding the K13 mutant and repeating the hierarchical clustering and bootstrap analysis still produces a highly significant cluster ( p < 0.05) containing the other mutants in the ART sensitivity cluster from the original analysis (data not shown).

Table 3 shows highly significant differences between both groups of patients with age ≥ 8 years as regards UCVA and BCVA at visits 2, 3, and 4 ( p < 0.05).

(3) In the non-running rats, the Mankin score of the PEE group showed an increasing trend compared to that of the control group ( P > 0.05).

The interaction term did not reach statistical significance (p-value < 0.05) for any of the subgroups.

Superficial SWIs data were available from 8 studies: RAD was associated with a significant, over 45% reduction of the odds of SSWI: OR (95%CIs): 0.54 (0.32–0.90); p = 0.01; I 2 = 63%; that reached borderline significance in gentamicin studies (0.55 (0.30–1.01); p = 0.05; I 2 = 70%; P heterogeneity for between subgroups comparison = 0.71.

After adjusting for 26 potential confounders, the association between eGFR-CHD was slightly attenuated and remained borderline significant (OR = 0.868 per 10 ml/min/1.73 m 2 increase, 95% CI = 0.760–1.000, p = 0.05).